TherapeuticsMD | TXMD - Current Liabilities


TherapeuticsMD reported $5.82M in Current Liabilities for its fiscal quarter ending in June of 2024.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Novo Nordisk DKK 32.79B 203.33B Jun/2025
Pfizer USD 36.6B 1.13B Sep/2025
TherapeuticsMD USD 5.82M 655K Jun/2024